[22] Metoclopramide (Reglan) works by promoting gastric emptying, theoretically counteracting the GLP-1 mechanism, but carries a boxed warning for tardive dyskinesia and should not be used for longer than 12 weeks except in rare circumstances
Near the end of the BUD, any additional unrefrigerated time carries proportionally more risk
B12 deficiency is not a minor inconvenience
If you have both conditions, your doctor can prescribe Ozempic (semaglutide) for diabetes management, and weight loss becomes a beneficial side effect
The GLP-1 and GIP components function similarly to tirzepatide, providing appetite suppression, improved insulin dynamics, and reduced caloric intake
Tirzepatide (Zepbound, Mounjaro) produces 22.5% average weight loss and is the closest approved analog to retatrutides efficacy level